We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

altona Diagnostics GmbH

altona Diagnostics GmbH develops and commercializes real-time PCR based assays and molecular diagnostic test solution... read more Featured Products: More products

Download Mobile App





Altona Diagnostics Exhibits AltoStar Product Range at ECCMID 2022

By LabMedica International staff writers
Posted on 22 Apr 2022

Altona Diagnostics GmbH (Hamburg, Germany) exhibited its AltoStar product line of automated real-time PCR testing solutions suitable for high-throughput laboratories at ECCMID 2022. More...

The event brought together the best and brightest in the field of clinical microbiology and infectious diseases from all over the world.

The flexible and efficient AltoStar Molecular Diagnostic Workflow automates your PCR analyses from sample extraction to PCR results and enables full traceability. At ECCMID 2022, altona demonstrated the AltoStar Automation System AM16, a pipetting workstation, in combination with the AltoStar Connect software, is the centerpiece of the AltoStar Workflow. It is intended to be used in combination with the AltoStar Purification Kit 1.5, the AltoStar Internal Control 1.5 and altona Diagnostics PCR kits for automated purification of nucleic acids and automated assay setup for in vitro diagnostic purposes.

The AltoStar Connect software used to operate the AltoStar Automation System AM16 is a time-saving state-of-the-art application software that provides loading dialogue to guide through each loading step in order to ensure the completeness of the set up procedure. It can be connected to one or several real-time PCR instruments for their automatic programming and allows sample information and worklist to be imported via barcode reader or LIMS. It features predefined purification protocols and offers automated selection of controls and standards.

In addition, altona presented the AltoStar reagents that are altona Diagnostics-specific products, which are part of the workflow based on AltoStar AM16 and AltoStar Connect software. The AltoStar PCR kits are based on real-time PCR technology, utilizing PCR for amplification of specified target sequences and target-specific probes in order to detect amplified DNA or RNA. The AltoStar Purification Kit 1.5 uses magnetic particle technology and is intended to be used for automated isolation and purification of nucleic acids from specified human specimens for in vitro diagnostic purposes. It permits simultaneous purification of RNA and DNA from multiple sample types. The AltoStar Internal Control 1.5 is intended to be used as a nucleic acid extraction, amplification and detection control for in vitro diagnostic purposes. The control contains the internal purification control and is added at the beginning of the purification procedure. All tubes and containers of the AltoStar Purification Kit 1.5, the AltoStar Internal Control 1.5 and the AltoStar PCR Kit 1.5 are barcoded by the AltoStar system for automated identification, localization and verification of lot conformity, as well as non-expiry.

Related Links:
altona Diagnostics GmbH 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Immunoassay Analyzer
Procise DX
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image Credit: Adobe Stock

Machine Learning Cytology Tool Improves Cancer Cell Identification

Cytological screening remains central to early cancer detection, but its accuracy depends heavily on expert interpretation of stained cells. Under conventional microscopy, malignant and reactive cells... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.